Enterprise HL7 / FHIR Terminology Engine
Universal Clinical Codes & Terminology Search
Search, verify, and inspect standardized LOINC, SNOMED CT, ICD-10-CM, RxNorm, and CPT clinical codes with native HL7 FHIR R4 resource mappings.
Showing 20 of 12623 codes
Per page:
Need to map or validate codes in bulk?
Cross-reference up to 1,000 ICD-10, LOINC, and CPT records simultaneously in memory with our free utility.
| Code Value | Display Description | Code System & OID | FHIR Resource | Category | Status | Actions |
|---|---|---|---|---|---|---|
|
0553T
|
Percutaneous transcatheter placement of iliac arteriovenous anastomosis implant inclusive of all radiological supervision and interpretation intraprocedural roadmapping and imaging guidance necessary to complete the intervention
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0553U
|
Reproductive medicine (preimplantation genetic assessment) analysis of 24 chromosomes using DNA genomic sequence analysis from embryonic trophectoderm for structural rearrangements aneuploidy and a mitochondrial DNA score results reported as normal/balanced (euploidy/balanced) unbalanced structural rearrangement monosomy trisomy segmental aneuploidy or mosaic per embryo tested
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0554T
|
Bone strength and fracture risk using finite element analysis of functional data and bone-mineral density utilizing data from a computed tomography scan; retrieval and transmission of the scan data assessment of bone strength and fracture risk and bone mineral density interpretation and report
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0554U
|
Reproductive medicine (preimplantation genetic assessment) analysis of 24 chromosomes using DNA genomic sequence analysis from trophectoderm biopsy for aneuploidy ploidy a mitochondrial DNA score and embryo quality control results reported as normal (euploidy) monosomy trisomy segmental aneuploidy triploid haploid or mosaic with quality control results reported as contamination detected or inconsistent cohort when applicable per embryo tested
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0555F
|
Symptom management plan of care documented (HF)
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Patient Management | Active |
|
|
0555T
|
Bone strength and fracture risk using finite element analysis of functional data and bone-mineral density utilizing data from a computed tomography scan; retrieval and transmission of the scan data
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0555U
|
Reproductive medicine (preimplantation genetic assessment) analysis of 24 chromosomes using DNA genomic sequence analysis from embryonic trophectoderm for structural rearrangements aneuploidy ploidy a mitochondrial DNA score and embryo quality control results reported as normal/balanced (euploidy/balanced) unbalanced structural rearrangement monosomy trisomy segmental aneuploidy triploid haploid or mosaic with quality control results reported as contamination detected or inconsistent cohort when
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0556F
|
Plan of care to achieve lipid control documented (CAD)
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Patient Management | Active |
|
|
0556T
|
Bone strength and fracture risk using finite element analysis of functional data and bone-mineral density utilizing data from a computed tomography scan; assessment of bone strength and fracture risk and bone mineral density
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0556U
|
Infectious disease (bacterial or viral respiratory tract infection) pathogen-specific DNA and RNA by real-time PCR 12 targets nasopharyngeal or oropharyngeal swab including multiplex reverse transcription for RNA targets each analyte reported as detected or not detected
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0557F
|
Plan of care to manage anginal symptoms documented (CAD)
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Patient Management | Active |
|
|
0557T
|
Bone strength and fracture risk using finite element analysis of functional data and bone-mineral density utilizing data from a computed tomography scan; interpretation and report
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0557U
|
Infectious disease (bacterial vaginosis and vaginitis) real-time amplification of DNA markers for Atopobium vaginae Gardnerella vaginalis Megasphaera types 1 and 2 bacterial vaginosis associated bacteria-2 and -3 (BVAB-2 BVAB-3) Mobiluncus species Trichomonas vaginalis Neisseria gonorrhoeae Candida species (C. albicans C. tropicalis C. parapsilosis C. glabrata C. krusei) Herpes simplex viruses 1 and 2 vaginal fluid reported as detected or not detected for each organism
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0558T
|
Computed tomography scan taken for the purpose of biomechanical computed tomography analysis
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0558U
|
Oncology (colorectal) quantitative enzyme-linked immunosorbent assay (ELISA) for secreted colorectal cancer protein marker (BF7 antigen) using serum result reported as indicative of response/no response to therapy or disease progression/regression
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0559T
|
Anatomic model 3D-printed from image data set(s); first individually prepared and processed component of an anatomic structure
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0559U
|
Oncology (breast) quantitative enzyme-linked immunosorbent assay (ELISA) for secreted breast cancer protein marker (BF9 antigen) serum result reported as indicative of response/no response to therapy or disease progression/regression
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0560T
|
Anatomic model 3D-printed from image data set(s); each additional individually prepared and processed component of an anatomic structure (List separately in addition to code for primary procedure)
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0560U
|
Oncology (minimal residual disease [MRD]) genomic sequence analysis cell-free DNA whole blood and tumor tissue baseline assessment for design and construction of a personalized variant panel to evaluate current MRD and for comparison to subsequent MRD assessments
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0561T
|
Anatomic guide 3D-printed and designed from image data set(s); first anatomic guide
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
Healthcare Terminology & FHIR R4 Interoperability
Standardized coding guidelines governed by CodesForMD
In HL7 FHIR R4, discrete clinical findings and laboratory measurements are encapsulated inside
Observation resources. Diagnostic terms and problem list entries are represented within Condition resources, while surgical and therapeutic acts map to Procedure. CodesForMD adheres to official US Core and International FHIR Implementation Guides.
An OID is an internationally standardized dotted-decimal identifier (e.g.
2.16.840.1.113883.6.1 for LOINC) registered with HL7 and ISO. OIDs ensure unambiguous identification of terminology authorities when exchanging clinical messages across heterogeneous EHR, LIS, and PACS systems.
Yes. You can visit our platform's administrative ingestion and export engine or contact our team to obtain batch files of standardized codes.